$AIM AIM ImmunoTech has received a Notice of Allowance for U.S. Patent Application No. 17/416,358 on June 5, 2026 titled “Compositions and Methods for Cancer Therapy.”
https://t.co/CewttCoRGd
$CING Cingulate has received a Notice of Allowance for U.S. Patent Application No. 18/838,775 on May 28, 2026 titled “Trimodal, Precision-Timed Pulsatile Release Tablet.”
https://t.co/HkYLRjr8fg
$DFLI Dragonfly Energy has received a Notice of Allowance on May 11, 2026 for U.S. Patent Application No. 18/161,875 titled “Powderized Solid-State Electrolyte and Electroactive Materials.”
https://t.co/yaG0AIzSyo
$MBRX Moleculin Biotech has received a Notice of Allowance on April 28, 2026 for U.S. Patent Application No. 17/906,459 titled “Method of Treating Viral Infections with Hexose Type Monosaccharides and Analogs Thereof.”
https://t.co/rEx5EzQqXz
$NUWE Nuwellis has received a Notice of Allowance on April 24, 2026 for U.S. Patent Application No. 18/259,973 titled “Dual Lumen Catheter.”
https://t.co/SOx1IrgPh4
$AUUD Auddia has received a Notice of Allowance on April 14, 2026 for U.S. Patent Application No. 18/436,143 titled “Identifying Shifts in Audio Content via Machine Learning.”
https://t.co/44eDshWxou
$ACON Aclarion will be granted U.S. Patent No. 12,601,803 on April 14, 2026 titled “System for Machine Learning-Based Model Training and Prediction for Evaluation of Pain.”
https://t.co/CKdmvshg19
$IDAI T Stamp has received a Notice of Allowance on March 18, 2026 for U.S. Patent Application No. 18/828,671 titled “Multi-Factor Authentication Using Tamper-Resistant Band and Biometric Data.”
https://t.co/H1dRUFO3i7
$CING Cingulate has received a Notice of Allowance for U.S. Patent Application No. 18/560,039 on March 17, 2026 titled “Trimodal, Precision-Timed Pulsatile Release Tablet.”
https://t.co/Osyhea4iBi
$ACOG Alpha Cognition has been granted U.S. Patent No. 12,551,491 titled “Dosage Regimens for Benzgalantamine.” The patent is “for the treatment of mild to moderate dementia of the Alzheimer’s type.”
https://t.co/hVpZTPApqN
$BIAF BioAffinity Technologies has been granted U.S. Patent No. 12,542,215 titled “Detection of Early-Stage Lung Cancer Sputum Using Automated Flow Cytometry and Machine Learning.”
https://t.co/Ffz0Nh8Ozf
$ALGS Aligos Therapeutics has been granted U.S. Patent No. 12,534,450 titled “Methods and Compositions for Targeting PD-L1.” The patent is for the “treatment of PD-L1 related diseases including but not limited to liver diseases, cancer, hepatocellular carcinoma, viral diseases, or hepatitis B.”
https://t.co/uAWof9Fu8r
$NRSN NeuroSense Therapeutics has been granted U.S. Patent No. 12,527,768 titled “Compositions Comprising an Anti-Inflammatory Drug and a Dicer Activator for use in the Treatment of Neuronal Diseases.” Patent is for treating neurodegenerative diseases such as Parkinson’s and Alzheimer’s.
https://t.co/JqDdHgOJ5P
$TENX Tenax Therapeutics has received a Notice of Allowance for U.S. Patent Application No. 17/545,386 titled “Pharmaceutical Compositions for Subcutaneous Administration of Levosimendan.”
https://t.co/zX5vgtkdsW
$XAIR Beyond Air has been granted U.S. Patent No. 12,478,640 titled “Inhalation of Nitric Oxide for Treating Respiratory Diseases.”
https://t.co/IQBf42FU91
$IBIO iBio has been granted U.S. Patent No. 12,473,368 on November 18, 2025 titled “CD25 Antibodies.” Patent is for “the treatment of cancer or autoimmune diseases.”
https://t.co/Z7mdGuwfBe
$ENSC Ensysce Biosciences has received a Notice of Allowance for U.S. Patent Application No. 17/689,255 on November 12, 2025 titled “Modified Release Compositions of Nafamostat and Methods of Using Same.”
https://t.co/nLGJaWw2av